These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 30716067)
1. Neuroprotective effects of PPARα in retinopathy of type 1 diabetes. Pearsall EA; Cheng R; Matsuzaki S; Zhou K; Ding L; Ahn B; Kinter M; Humphries KM; Quiambao AB; Farjo RA; Ma JX PLoS One; 2019; 14(2):e0208399. PubMed ID: 30716067 [TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina. Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models. Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999 [TBL] [Abstract][Full Text] [Related]
5. Protective and antioxidant effects of PPARα in the ischemic retina. Moran E; Ding L; Wang Z; Cheng R; Chen Q; Moore R; Takahashi Y; Ma JX Invest Ophthalmol Vis Sci; 2014 May; 55(7):4568-76. PubMed ID: 24825105 [TBL] [Abstract][Full Text] [Related]
6. Pathogenic Role of Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521 [TBL] [Abstract][Full Text] [Related]
7. A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism. Shao Y; Chen J; Dong LJ; He X; Cheng R; Zhou K; Liu J; Qiu F; Li XR; Ma JX Diabetes; 2019 Nov; 68(11):2131-2142. PubMed ID: 31451517 [TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction. Hu Y; Chen Y; Ding L; He X; Takahashi Y; Gao Y; Shen W; Cheng R; Chen Q; Qi X; Boulton ME; Ma JX Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15401-6. PubMed ID: 24003152 [TBL] [Abstract][Full Text] [Related]
9. The Protective Role of Microglial PPARα in Diabetic Retinal Neurodegeneration and Neurovascular Dysfunction. Yuan T; Dong L; Pearsall EA; Zhou K; Cheng R; Ma JX Cells; 2022 Dec; 11(23):. PubMed ID: 36497130 [TBL] [Abstract][Full Text] [Related]
10. Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt/β-catenin pathway activation. Liu Q; Zhang X; Cheng R; Ma JX; Yi J; Li J Cell Tissue Res; 2019 May; 376(2):165-177. PubMed ID: 30610453 [TBL] [Abstract][Full Text] [Related]
11. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type 1 diabetes. Aung MH; Park HN; Han MK; Obertone TS; Abey J; Aseem F; Thule PM; Iuvone PM; Pardue MT J Neurosci; 2014 Jan; 34(3):726-36. PubMed ID: 24431431 [TBL] [Abstract][Full Text] [Related]
12. Pathogenic role of human C-reactive protein in diabetic retinopathy. Qiu F; Ma X; Shin YH; Chen J; Chen Q; Zhou K; Wu W; Liang W; Wu Y; Song Q; Ma JX Clin Sci (Lond); 2020 Jul; 134(13):1613-1629. PubMed ID: 32602547 [TBL] [Abstract][Full Text] [Related]
13. Regulation of Monocyte Activation by PPARα Through Interaction With the cGAS-STING Pathway. Dong L; Cheng R; Ma X; Liang W; Hong Y; Li H; Zhou K; Du Y; Takahashi Y; Zhang X; Li XR; Ma JX Diabetes; 2023 Jul; 72(7):958-972. PubMed ID: 37058417 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effect of levetiracetam in mouse diabetic retinopathy: Effect on glucose transporter-1 and GAP43 expression. Mohammad HMF; Sami MM; Makary S; Toraih EA; Mohamed AO; El-Ghaiesh SH Life Sci; 2019 Sep; 232():116588. PubMed ID: 31226418 [TBL] [Abstract][Full Text] [Related]
15. Retinal neuroprotective effects of quercetin in streptozotocin-induced diabetic rats. Kumar B; Gupta SK; Nag TC; Srivastava S; Saxena R; Jha KA; Srinivasan BP Exp Eye Res; 2014 Aug; 125():193-202. PubMed ID: 24952278 [TBL] [Abstract][Full Text] [Related]
16. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis. Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395 [TBL] [Abstract][Full Text] [Related]
17. Pregabalin affords retinal neuroprotection in diabetic rats: Suppression of retinal glutamate, microglia cell expression and apoptotic cell death. Ali SA; Zaitone SA; Dessouki AA; Ali AA Exp Eye Res; 2019 Jul; 184():78-90. PubMed ID: 31002823 [TBL] [Abstract][Full Text] [Related]
18. Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina. Al-Dosari DI; Ahmed MM; Al-Rejaie SS; Alhomida AS; Ola MS Nutrients; 2017 Oct; 9(10):. PubMed ID: 29064407 [TBL] [Abstract][Full Text] [Related]
19. DNMT1-mediated PPARα methylation aggravates damage of retinal tissues in diabetic retinopathy mice. Zhu Y; Wang X; Zhou X; Ding L; Liu D; Xu H Biol Res; 2021 Aug; 54(1):25. PubMed ID: 34362460 [TBL] [Abstract][Full Text] [Related]
20. Effect of berberine on PPARalpha/delta/gamma expression in type 2 diabetic rat retinae. Zhou JY; Zhou SW Yao Xue Xue Bao; 2007 Dec; 42(12):1243-9. PubMed ID: 18338635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]